JPH05310529A - Cosmetic or ornamentation - Google Patents
Cosmetic or ornamentationInfo
- Publication number
- JPH05310529A JPH05310529A JP4134328A JP13432892A JPH05310529A JP H05310529 A JPH05310529 A JP H05310529A JP 4134328 A JP4134328 A JP 4134328A JP 13432892 A JP13432892 A JP 13432892A JP H05310529 A JPH05310529 A JP H05310529A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- capsules
- capsule
- carrageenan
- contents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 17
- 239000002775 capsule Substances 0.000 claims abstract description 29
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 13
- 239000000679 carrageenan Substances 0.000 claims abstract description 13
- 229920001525 carrageenan Polymers 0.000 claims abstract description 13
- 229940113118 carrageenan Drugs 0.000 claims abstract description 13
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 13
- 229920001817 Agar Polymers 0.000 claims abstract description 11
- 239000008272 agar Substances 0.000 claims abstract description 11
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 claims abstract description 7
- 239000002304 perfume Substances 0.000 abstract description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940114069 12-hydroxystearate Drugs 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 9
- 239000012071 phase Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical group CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CKDZWMVGDHGMFR-UHFFFAOYSA-N Buttersaeure-cholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCC)C2 CKDZWMVGDHGMFR-UHFFFAOYSA-N 0.000 description 2
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- CKDZWMVGDHGMFR-GTPODGLVSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] butanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCC)C1 CKDZWMVGDHGMFR-GTPODGLVSA-N 0.000 description 2
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000008385 outer phase Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- KXWDMNPRHKRGKB-DYQRUOQXSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] heptanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCC)C1 KXWDMNPRHKRGKB-DYQRUOQXSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Description
【０００１】[0001]
【産業上の利用分野】本発明は塗布したときにカプセル
のカス等が残らず官能面で優れており、且つ美的外観を
そなえ、有効性を付加したカプセルとそれを液状物で覆
うことを特徴とする化粧料および装飾品に関する。BACKGROUND OF THE INVENTION The present invention is characterized in that capsules which are not left behind when applied are excellent in terms of sensory aspect, have an aesthetic appearance, and have added effectiveness, and that they are covered with a liquid substance. And cosmetics and ornaments.
【０００２】[0002]
【従来の技術】従来、カプセルの成分としてゼラチン、
寒天やアルギン酸塩等が汎用されていた。しかしなが
ら、これらの成分では、皮膚に塗布時、カプセル剤がス
ムーズに溶解・破壊・展延せず、違和感がある。また、
液体中にカプセルを整然と一定間隔で配列した状態でこ
の混合系を維持するためには外相粘度を高くし、粘度で
カプセルを液中に均一分散させておく方法が行われてい
たが、この場合皮膚に塗布時、塗布感が重く伸展性が低
く、化粧品として問題があった。また、このような製剤
の場合、外観上も今までの化粧料とは異なっており、さ
らによりよい外観を求められている。2. Description of the Related Art Conventionally, gelatin has been used as a capsule ingredient.
Agar and alginate were widely used. However, with these ingredients, when applied to the skin, the capsule does not dissolve, break, and spread smoothly, and there is a feeling of strangeness. Also,
In order to maintain this mixed system in the state where the capsules are regularly arranged in the liquid at regular intervals, a method of increasing the external phase viscosity and uniformly dispersing the capsules in the liquid by the viscosity was used. When applied to the skin, the feeling of application was heavy and the extensibility was low, which was a problem as a cosmetic product. Further, in the case of such a preparation, the appearance is different from that of the conventional cosmetics, and an even better appearance is required.
【０００３】[0003]
【発明が解決しようとする課題】本発明の目的は皮膚に
適用したとき、カプセル剤がスムーズに破壊、展延し、
膜カスが残らず塗布感等に違和感がなく、製品として
も、美観を有し、且つ化粧品としての有効性を具備した
ものを提供することにある。DISCLOSURE OF THE INVENTION The object of the present invention is that when applied to the skin, the capsules break and spread smoothly,
It is an object of the present invention to provide a product which has no film residue and which does not give an uncomfortable feeling in application and the like, and which has a beautiful appearance as a product and is effective as a cosmetic product.
【０００４】[0004]
【課題を解決するための手段】発明者らはすでに化粧
品、食用等で利用され、安全性が確認されている成分を
鋭意検討した結果、カプセル皮膜成分として寒天に親水
性造膜性の高分子であるカラゲーナンを配合するとカプ
セルの破壊・展延性、皮膚への違和感等の面で非常に有
用であることがわかった。すなわち本発明は、（１）
寒天とカラゲーナンを特徴成分とするカプセルを含む化
粧料又は装飾品であり、（２） 内包される成分がコレ
ステリック液晶である前項（１）のカプセルを含む化粧
料又は装飾品である。カラゲーナンの種類はカッパ、イ
オタ、ラムダの３種類があるが特に限定はないが、その
中でもカッパ型が好ましいことも分かった。すなわち、
他の成分、寒天やカラゲーナンの種類、或いは配合量に
よって変化するが寒天を１に対してカラゲーナン２〜６
好ましくは３〜５、配合量も他の成分、寒天やカラゲー
ナンの種類や配合比率によって変化するが寒天を０．１
〜５．０重量％、好ましくは０．２〜０．５重量％、カ
ラゲーナンを１．０〜５．０重量％、好ましくは１．２
〜１．６重量％を配合する。[Means for Solving the Problems] The inventors of the present invention have made diligent studies on components which have already been used in cosmetics, foods, etc. and have been confirmed to be safe. It has been found that the addition of carrageenan is very useful in terms of capsule breakage / spreadability, discomfort to the skin, and the like. That is, the present invention provides (1)
A cosmetic or a decorative product including a capsule containing agar and carrageenan as characteristic components, and (2) a cosmetic or a decorative product including the capsule of the above item (1) in which the contained component is a cholesteric liquid crystal. There are three types of carrageenan, kappa, iota, and lambda, but there is no particular limitation, but it was also found that the kappa type is preferable. That is,
Carrageenan 2 to 6 for 1 agar, depending on other ingredients, type of agar and carrageenan, or blending amount
It is preferably 3 to 5 and the compounding amount is 0.1 depending on other components such as agar or carrageenan and the compounding ratio.
-5.0 wt%, preferably 0.2-0.5 wt%, carrageenan 1.0-5.0 wt%, preferably 1.2
~ 1.6 wt% is compounded.
【０００５】また、その他の化粧品原料として配合でき
る水溶性の原料は塗布感等に害を与えない範囲で利用で
きる。一方、カプセルの内包する物質として油溶性の物
質にするときは特にコレステリック液晶を利用するとそ
の外観の優位性や保湿性が有効に活かせる。コレステリ
ック液晶のなかでもコレステリル１２‐ヒドロキシステ
アレートを含むものが一番最適であった。液晶の組成は
特開平２−２２３５０６号、特願平１−４３２５５号、
特願平２−２３２５７３号のように作成すればよい。こ
れに加えて、アコヤ貝のステロール類等を加えるとさら
に有効である。Further, other water-soluble raw materials that can be blended as cosmetic raw materials can be used within a range that does not impair the application feeling. On the other hand, when an oil-soluble substance is used as the substance to be encapsulated in the capsule, particularly when cholesteric liquid crystal is used, the superiority of its appearance and the moisturizing property can be effectively utilized. Among the cholesteric liquid crystals, the one containing cholesteryl 12-hydroxystearate was the most suitable. The composition of the liquid crystal is described in JP-A-2-223506, JP-A-1-43255,
It may be created as in Japanese Patent Application No. 2-232573. In addition to this, it is more effective to add pearl sterols and the like.
【０００６】カプセルの形状は球形、楕円形、円筒形等
特に限定されない。内包物と外相がカプセルで隔てられ
ているため、成分間で作用しあい、劣化しやすいもの等
を分けて配合できるため、いろいろな利点が発生するこ
ともひとつの優位点である。さらに本カプセルはカプセ
ル皮膜が柔らかくカプセル皮膜を厚くしても使用感がよ
く、且つこの皮膜は透明性が高く皮膜率を高くすること
により、皮膜の厚さで物理的にカプセルが固定され、各
カプセルを一定間隔で整然として配合することができ、
外相粘度を最適に設定でき、塗布感等の官能性をよりよ
い状態に設定出来る。またカプセルの成形法はローター
ダイ式ソフトカプセル製造法、滴下法など公知の方法を
用いる。本発明を実施して内包物に香料等を配合すると
徐放性になり、カーコロンやその外観上の優位点から室
内装飾品に利用できることも判明した。The shape of the capsule is not particularly limited to a spherical shape, an elliptical shape, a cylindrical shape or the like. One of the advantages is that since the encapsulated substance and the external phase are separated by capsules, components that act with each other and easily deteriorate can be mixed separately, and thus various advantages are generated. Furthermore, this capsule has a soft capsule film and has a good feeling of use even if the capsule film is thickened, and this film has high transparency and a high film rate, so that the capsule is physically fixed by the thickness of the film, Capsules can be blended regularly at regular intervals,
The outer phase viscosity can be optimally set, and the functionalities such as application feeling can be set in a better state. As the capsule molding method, known methods such as a rotor die type soft capsule manufacturing method and a dropping method are used. It has also been found that when the present invention is carried out and a fragrance or the like is added to the inclusion, the composition has a sustained release property and can be used as an interior decoration product because of its superiority in car colon and its appearance.
【０００７】（実施例１） カプセル剤 （重量％） 寒 天 ０．６％ カラゲーナン １．７％ 防腐剤 ０．１％ 精製水 ９７．６％ 内包物 コレステリル１２‐ヒドロキシステアレート ５０．０％ コレステリルヘプタノエート ２０．０％ コレステリルオレエート １５．０％ コレステリルブチレート １０．０％ ビタミンＥ ５．０％ 外 相 精製水 ８５．０％ ヒアルロン酸Ｎａ ０．２％ グリセリン １０．０％ １，３ブチレングリコール ４．７％ 防腐剤 ０．１％ （製造方法）カプセル剤、内包物、外相をそれぞれ別に
計量し撹拌しつつ溶解する。カプセル剤は７０℃、内包
物７５℃まで加熱する。カプセル剤２部と内包物１部を
二重オリフィスにより液中硬化法にてカプセルを成形す
る。これに外相を１部加える。(Example 1) Capsule (% by weight) Agar 0.6% Carrageenan 1.7% Preservative 0.1% Purified water 97.6% Encapsulation cholesteryl 12-hydroxystearate 50.0% Cholesteryl Heptanoate 20.0% Cholesteryl oleate 15.0% Cholesteryl butyrate 10.0% Vitamin E 5.0% External phase purified water 85.0% Na hyaluronate 0.2% Glycerin 10.0% 1,3 Butylene glycol 4.7% Preservative 0.1% (Production method) Capsules, inclusions, and external phase are weighed separately and dissolved with stirring. The capsules are heated to 70 ° C and the inclusions to 75 ° C. Two parts of the capsule and one part of the encapsulated product are molded into a capsule by a submerged curing method using a double orifice. To this is added 1 part external phase.
【０００８】（実施例２） カプセル剤 （重量％） 寒 天 ０．３％ カラゲーナン １．０％ 防腐剤 ０．１％ 精製水 ９８．６％ 内包物 コレステリル１２‐ヒドロキシステアレート ４０．０％ コレステリルオレエート ３０．０％ コレステリルブチレート ２５．０％ アコヤ貝のステロール類 ５．０％ 外 相 精製水 ８７．９％ コンキオリン加水分解液（２．５％） ２．０％ グリセリン １０．０％ 防腐剤 ０．１％ （製造方法）実施例１と同じ方法で作成した。Example 2 Capsule (wt%) Agar 0.3% Carrageenan 1.0% Preservative 0.1% Purified water 98.6% Encapsulation Cholesteryl 12-hydroxystearate 40.0% Cholesteryl Oleate 30.0% cholesteryl butyrate 25.0% pearl oyster sterols 5.0% outer phase purified water 87.9% conchiolin hydrolysis solution (2.5%) 2.0% glycerin 10.0% preservative Agent 0.1% (manufacturing method) Prepared in the same manner as in Example 1.
【０００９】使用テスト 女性４名づつの顔面を左右に分け、一方を実施例、もう
一方を比較例として毎日、１回以上使用してもらって、
１月後、アンケートした。なお、比較例は 比較例１は実施例１のカラゲーナンを寒天に置き換えた
もの 比較例２は実施例１のコレステリック液晶をスクワラン
に置き換えたもの 比較例３は実施例２のカラゲーナンを寒天に置き換えた
もの 比較例４は実施例２のコレステリック液晶をスクワラン
に置き換えたもの なお、１６名を４班にわけ、下記の表１の試料を使って
実験した。Usage test Each of the four women's faces was divided into left and right sides, one of which was used as an example and the other of which was used as a comparative example once or more daily,
After a month, I conducted a questionnaire. Comparative Examples are as follows: Comparative Example 1 in which the carrageenan of Example 1 was replaced with agar, Comparative Example 2 in which the cholesteric liquid crystal of Example 1 was replaced with squalane, and Comparative Example 3 in which the carrageenan of Example 2 was replaced with agar. Comparative Example 4 was the one in which the cholesteric liquid crystal of Example 2 was replaced with squalane. In addition, 16 people were divided into 4 groups, and experiments were conducted using the samples in Table 1 below.
【００１０】[0010]
【表１】 判定基準は以下のようでアンケートの結果をまとめたの
が以下の表２である。 実施例の方が非常によい ３ 実施例の方がかなりよい ２ 実施例の方がややよい １ 差がない ０ 比較例の方がややよい −１ 比較例の方がかなりよい −２ 比較例の方が非常によい −３[Table 1] The judgment criteria are as follows, and the results of the questionnaire are summarized in Table 2 below. Example is very good 3 Example is considerably good 2 Example is slightly good 1 No difference 0 Comparative example is good −1 Comparative example is good −2 Comparative example Is very good -3
【００１１】[0011]
【表２】 [Table 2]
【００１２】[0012]
【発明の効果】化粧料として皮膚に適用したとき、カプ
セル剤がスムースに破壊、展延し、膜カスが残らず、塗
布感に違和感がない。又製品としても美観を呈し、内包
物に香料を配合すると、徐放性になり、室内装飾品とし
ても利用できる。EFFECTS OF THE INVENTION When applied as a cosmetic to the skin, the capsule smoothly breaks and spreads, no film residue remains, and the application feeling is not uncomfortable. In addition, when it has a beautiful appearance as a product and a perfume is added to the inclusion, it becomes a sustained release and can be used as an interior decoration.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 ＦＩ 技術表示箇所 Ａ６１Ｋ 7/48 9051−4Ｃ // Ｃ０９Ｋ 19/36 7457−4Ｈ ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location A61K 7/48 9051-4C // C09K 19/36 7457-4H
Claims (2)
プセルを含む化粧料又は装飾品。1. A cosmetic or ornamental product containing capsules containing agar and carrageenan as characteristic components.
ある請求項１のカプセルを含む化粧料又は装飾品。2. A cosmetic or ornamental product containing the capsule according to claim 1, wherein the contained component is a cholesteric liquid crystal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13432892A JP3176984B2 (en) | 1992-04-28 | 1992-04-28 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13432892A JP3176984B2 (en) | 1992-04-28 | 1992-04-28 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05310529A true JPH05310529A (en) | 1993-11-22 |
| JP3176984B2 JP3176984B2 (en) | 2001-06-18 |
Family
ID=15125763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13432892A Expired - Fee Related JP3176984B2 (en) | 1992-04-28 | 1992-04-28 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3176984B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6340473B1 (en) | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| JP2007503417A (en) * | 2003-08-27 | 2007-02-22 | バイヤースドルフ・アクチエンゲゼルシヤフト | Spherical cosmetic formulation for topical application |
| JP2007503418A (en) * | 2003-08-27 | 2007-02-22 | バイヤースドルフ・アクチエンゲゼルシヤフト | Capsule with outer skin that becomes individually undetectable during topical use |
| JP2008174634A (en) * | 2007-01-18 | 2008-07-31 | Chisso Corp | Cholesteric liquid crystal composition |
| JP2021506744A (en) * | 2017-12-18 | 2021-02-22 | エルブイエムエイチ レシェルシェ | Liquid cosmetics containing capsules |
| KR102415878B1 (en) * | 2021-03-11 | 2022-06-30 | 주식회사 현대바이오랜드 | Colesteric liquid crystal-encapsulated complex coacervate particles and cosmetic composition comprising the same |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102036141B1 (en) * | 2017-12-20 | 2019-10-28 | 주식회사 아이젤 | Cosmetic Composition Containing Cholesteric Liquid Crystal With Dual Capsule Process |
-
1992
- 1992-04-28 JP JP13432892A patent/JP3176984B2/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6340473B1 (en) | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| US6582727B2 (en) | 1999-07-07 | 2003-06-24 | R. P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| USRE39079E1 (en) * | 1999-07-07 | 2006-04-25 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| JP2007503417A (en) * | 2003-08-27 | 2007-02-22 | バイヤースドルフ・アクチエンゲゼルシヤフト | Spherical cosmetic formulation for topical application |
| JP2007503418A (en) * | 2003-08-27 | 2007-02-22 | バイヤースドルフ・アクチエンゲゼルシヤフト | Capsule with outer skin that becomes individually undetectable during topical use |
| JP2008174634A (en) * | 2007-01-18 | 2008-07-31 | Chisso Corp | Cholesteric liquid crystal composition |
| JP2021506744A (en) * | 2017-12-18 | 2021-02-22 | エルブイエムエイチ レシェルシェ | Liquid cosmetics containing capsules |
| US11478410B2 (en) | 2017-12-18 | 2022-10-25 | Lvmh Recherche | Liquid cosmetic with agar shell capsule |
| KR102415878B1 (en) * | 2021-03-11 | 2022-06-30 | 주식회사 현대바이오랜드 | Colesteric liquid crystal-encapsulated complex coacervate particles and cosmetic composition comprising the same |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3176984B2 (en) | 2001-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4660196B2 (en) | Density-controlled particle suspension for food, cosmetics, pharmaceuticals and other uses | |
| EP1176941B1 (en) | Multi-phase antiperspirant stick | |
| ZA200107667B (en) | Antiperspirant compositions. | |
| KR101768710B1 (en) | Manufacturing method of eyelash extension patch having wrinkle-improving function | |
| JPH05194144A (en) | Cosmetic composition in solid gel form and method for its production | |
| CA2229787A1 (en) | Cosmetic gel composition having reduced skin irritation | |
| JPH02117610A (en) | Cosmetic containing capsule involving emulsion | |
| JPH05310529A (en) | Cosmetic or ornamentation | |
| JP2985083B2 (en) | External preparation for skin | |
| JPH06116120A (en) | Aqueous powder-containing cosmetic | |
| US4963350A (en) | Liquid shaving product | |
| JP2003113036A (en) | Gel-like composition | |
| JP2000239139A (en) | Skin cosmetic | |
| JP2731845B2 (en) | Transparent gel cosmetic with linear pattern | |
| JP2708699B2 (en) | Bath composition | |
| DE2405216A1 (en) | COSMETIC PRODUCTS, THESE ANTI-antiperspirants, AND PROCESS FOR THEIR MANUFACTURING | |
| KR20220027633A (en) | Cosmetic Composition Containing LHA Crystal Pearl Effective For Improving Skin Trouble | |
| JP2022011029A (en) | Granular cosmetics and cosmetics containing granular cosmetics | |
| JPS635011A (en) | Agar film capsule-containing composition for makeup | |
| JP4370595B2 (en) | Gel composition, fragrance, external preparation for skin and cosmetics | |
| JP2732261B2 (en) | Skin composition | |
| KR20080074990A (en) | Soap composition with encapsulates | |
| JPS62243699A (en) | Frame kneading soap | |
| JPH031284B2 (en) | ||
| JPH07316057A (en) | Metabolic activator, skin preparation for external use and bathing agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |